Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 113.00
-3.00 (-2.59%)
At close: Feb 6, 2026
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 7.73 billion as of February 6, 2026. Its market cap has decreased by -57.55% in one year.
Market Cap
7.73B
Enterprise Value
6.81B
Revenue
727.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
113.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 7.73B, an increase of 1,545.51%. That is a compound annual growth rate of 21.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.73B | 6.23% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.65B |
| K Pharma,Inc. | 7.99B |
| MEDINET | 7.94B |
| CellSource | 7.87B |
| ADR120S | 7.76B |
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |